Skip to main content
. 2015 Oct 26;6(37):40327–40336. doi: 10.18632/oncotarget.5530

Table 1. Summary of GWA scan and replication studies for 4 SNPs consistent in three stages.

SNP Study Casesb Controlsb MAFc ORadd Padd P–Qd
Cases Controls (95% CI)
rs12522693 GWAS 16/242/673 13/172/780 0.15 0.10 1.55(1.27–1.89) 1.86 × 10−5
5q23.3 Replication I 34/404/1321 21/367/1487 0.13 0.11 1.27(1.10–1.46) 1.10 × 10−3
G/Aa Replication II 16/212/715 18/360/1460 0.13 0.11 1.23(1.04–1.46) 1.61 × 10−2
Combined All 1.31(1.19–1.45) 2.08 × 10−8 0.19
rs10035791 GWAS 23/272/635 17/208/740 0.17 0.13 1.51(1.25–1.82) 1.54 × 10−5
5q23.3 Replication I 42/463/1249 33/442/1386 0.16 0.14 1.17(1.03–1.33) 1.98 × 10−2
G/Aa Replication II 23/252/668 31/433/1366 0.16 0.14 1.20(1.03–1.41) 2.10 × 10−2
Combined All 1.25(1.14–1.36) 8.20 × 10−7 0.08
rs80007597 GWAS 13/230/688 9/162/793 0.14 0.09 1.59(1.29–1.96) 1.16 × 10−5
5q23.3 Replication I 27/386/1335 19/346/1493 0.13 0.10 1.25(1.08–1.45) 2.73 × 10−5
G/Ca Replication II 14/201/726 29/329/1475 0.12 0.11 1.17(0.98–1.39) 7.64 × 10−2
Combined All 1.29(1.17–1.42) 3.63 × 10−7 0.07
rs17836917 GWAS 6/130/796 21/179/765 0.08 0.11 0.64(0.51–0.80) 6.15 × 10−5
17q12 Replication I 12/308/1439 34/371/1470 0.09 0.12 0.79(0.68–0.92) 1.80 × 10−3
G/Aa Replication II 7/159/777 21/379/1438 0.09 0.11 0.78(0.65–0.94) 9.43 × 10−3
Combined All 0.75(0.68–0.83) 4.55 × 10−8 0.27
a

Major/minor alleles

b

Variant homozygote/Heterozygote/Wild type homozygote

c

Minor allele frequency (MAF)

ORadd, Padd: calculated by additive model adjusted for age, gender and first ten PC

d

P value of Cochran's Q test.